Trial · NCT05652621
Efficacy of Probiotics in Patients With IBD
This research group plans to take patients with mild to moderate UC and diarrhea IBS diagnosed in the First Affiliated Hospital of Xinxiang Medical College as e
- Status
- Recruiting
- Sponsor
- The First Affiliated Hospital of Xinxiang Medical College
- Study type
- Interventional
- Phase
- No phase
- Enrollment
- 200 participants (planned)
- Start
- Jul 31, 2022
- Primary completion
- Jan 31, 2024
- Conditions
- Ulcerative Colitis, Irritable Bowel Syndrome
Summary
This research group plans to take patients with mild to moderate UC and diarrhea IBS diagnosed in the First Affiliated Hospital of Xinxiang Medical College as examples, and divide them into UC group and IBS group; Each group was randomly divided into two groups, namely, conventional treatment+probiotics group and conventional treatment+probiotics placebo group.Starting from the intervention of probiotics on intestinal flora to alleviate intestinal injury caused by UC and IBS patients, the indicators of intestinal flora, serum inflammatory factors, metabolites in vivo, intestinal…
Interventions
- probiotics Dietary supplement
Locations
1 country: China.
| Facility | City | Country |
|---|---|---|
| The First Affiliated Hospital of Xinxiang Medical College | Xinxiang, Henan | China |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.